Drugs · acquisition-cost intelligence
Clobex
clobetasol propionate· ingredient clobetasolCorticosteroids, plain· CLOBETASOL PROPIONATE .05 g/100mL; CLOBETASOL PROPIONATE .5 mg/mL
What this is. Acquisition-cost intelligence for pharmacy & clinic buyers — the historical trend, generic-equivalent costs, and Part D posture. NADAC is a pharmacy acquisition cost (the national average pharmacies pay), not a retail or cash price — for consumer cash prices use GoodRx/your plan.
Acquisition benchmark · NADAC per ML
$0.24543
NADAC — pharmacy acquisition cost, not a retail/cash price
Acquisition-cost history
Weekly NADAC per ML — the trend nobody else shows. 6 weeks.
2025-12-172026-05-20
Same-ingredient options by acquisition cost
Other clobetasol products, cheapest acquisition cost first. Per ML — confirm strength/form equivalence before switching.
| Product | NADAC / ML | vs this |
|---|---|---|
| clobetasol propionate | $0.11487 | −$0.13060 |
| Clobetasol Propionate | $0.12147 | −$0.12400 |
| Clobetasol Propionate Cream 0.05% Clobetasol Propionate Cream 0.05% | $0.15938 | −$0.08600 |
| clobetasol propionate | $0.17794 | −$0.06750 |
| clobetasol propionate | $0.32513 | +$0.07970 |
| CLOBEX | $0.33318 | +$0.08780 |
| Clobex | $0.34854 | +$0.10310 |
| Clobetasol Propionate (emollient) | $0.58990 | +$0.34450 |
Medicare Part D coverage · CY2026
On 253 plan formularies · typical tier 4
Prior auth 0% · Step therapy 0% · Quantity limit 63% of formularies
Sources: CMS NADAC (pharmacy acquisition cost), FDA NDC + RxNorm (identity), RxClass (therapeutic class), CMS Medicare Part D formulary (coverage). Observed reference data for professional buyers — not a retail/cash price, not pricing or medical advice. Verify before purchasing or substituting.